Plastics injection molder Atalys LLC announced yesterday that it has acquired Schnipke Engraving Co. LLC. Both companies provide injection molding and related services to medical device OEMs. Atalys, based in Rochester, NY, said the acquisition will enhance its manufacturing capabilities, technology, and geographical footprint.Tight-tolerance molding a specialtyFounded in 1967, Schnipke has established a reputation for building tools in-house and designing and engineering molds that meet the medical device industry's stringent requirements for precision at extremely tight tolerances, said the news release.

塑料注射成型商Atalys LLC昨天宣布，它已经收购了Schnipke雕刻有限公司。两家公司都为医疗器械OEM提供注射成型和相关服务。总部位于纽约州罗切斯特的Atalys表示，此次收购将提高其制造能力、技术和地理足迹。新闻稿称，紧密公差成型是一家成立于1967年的专业公司，Schnipke在内部制造工具以及设计和工程模具方面树立了声誉，这些模具能够满足医疗器械行业在极其严格的公差下对精度的严格要求。

The company claims on its website that it can mold within tolerances of +/-0.001 inches and as small as 0.02 grams in weight. Even smaller dimensions can be accommodated upon customer request.Schnipke has tooling and plastic injection molding operations at its headquarters in Ottoville, OH, and operates a second manufacturing facility in Tucson, AZ.

该公司在其网站上声称，它可以在+/-0.001英寸的公差范围内成型，重量可以小到0.02克。可根据客户要求提供更小的尺寸。Schnipke在其位于俄亥俄州奥托维尔的总部拥有模具和塑料注射成型业务，并在亚利桑那州图森经营第二家制造工厂。

The company is FDA registered and is certified to ISO 13485:2016.Cleanroom molding and assemblyIn addition to its headquarters in Rochester, Atalys has manufacturing facilities in Asheboro, NC, and the Dominican Republic. The New York and North Carolina plants have multiple Class 8 cleanrooms for molding and assembly on site; the Santo Domingo site in the Dominican Republic offers cleanroom assembly and automation.

该公司是FDA注册的，并通过了ISO 13485:2016认证。洁净室成型和组装除了总部位于罗切斯特外，Atalys还在北卡罗来纳州阿什博罗和多米尼加共和国拥有生产设施。纽约和北卡罗来纳工厂有多个8级洁净室，用于现场成型和组装；多米尼加共和国的圣多明各工厂提供洁净室装配和自动化。

The company said it adheres to scientific molding principles and is equipped with presses ranging in size from “near micro molding” to 1,400 tons.'Our acquisition of Schnipke was driven by a focused strategy to deepen our capabilities, capacity, and technical superiority across the entire manufacturing process for medical device components,” said Vinc Ellerbrock, president and CEO of Atalys.

该公司表示，它坚持科学的成型原理，并配备了从“近微成型”到1400吨大小不等的压力机Atalys总裁兼首席执行官Vinc Ellerbrock表示：“我们对Schnipke的收购是由一项重点战略推动的，该战略旨在深化我们在医疗器械组件整个制造过程中的能力、产能和技术优势。”